NACT Use Appears to Be Increasing in Less Common Epithelial Ovarian Cancers

Patients with low-grade serous ovarian cancer appear to have worse survival outcomes following treatment with neoadjuvant chemotherapy (NACT).

Related Keywords

United States , ,National Cancer Database ,End Results ,Ovarian Cancer ,Enact ,Jama Network Open ,